MATERIAL AND METHODS

Intracellular Cytokine Staining
Frozen PBMCs from vaccinated NHPs were thawed, rested overnight, and stimulated for 6 hours with peptide pools in RPMI (Gibco, Invitrogen; supplemented with 2 mM L-glutamine, 100 IU/ml penicillin, 10 mg/ml streptomycin, and 10% heat-inactivated fetal bovine serum) in the presence of 10μg/ml BFA (Sigma Aldrich). Cells stimulated with 25ng/ml phorbol 12-myristate 13-acetate (PMA) and 1μg/ml of ionomycin (Sigma Aldrich) were used as a positive control. PBMCs were stained with surface antibodies including anti-CD3 Pacific Blue (SP34-2), anti-CD4 PerCP-Cy5.5 (L200), anti-CD8α APC-Cy7 (SK1), and anti-CD8β FITC (2ST8.5H7), in the presence of an Aqua LIVE/DEAD fixable dead cell marker (Invitrogen), for 30 minutes at 4°C. Cells were washed, fixed and permeabilized using the IntraPrep Fix/Perm Kit (Beckman Coulter) and incubated for 30 minutes at 4°C with antibodies specific for intracellular cytokines including anti-IL-2 PE (MQ1-17H12), antiinterferon (IFN)-γ PE-Cy7 (B27), and anti-tumor necrosis factor (TNF)-α APC (MAb11) before flow cytometric analysis (BD FACSCanto flow cytometer; BD Biosciences). Anti-CD8β FITC (2ST8.5H7) was custom-conjugated at Beckman Coulter whereas all other antibodies were obtained from BD Biosciences. 
